Metastatic ductal carcinoma of the prostate: a rare variant responding to a common treatment
DOI:
https://doi.org/10.5489/cuaj.830Abstract
Ductal carcinoma of the prostate is a rare histologic subtype ofprostate carcinoma. It represents 0.4% to 0.8% of all prostate
cancers and is associated with a poor prognosis. Given the paucity
of cases reported in the literature on ductal prostate carcinoma,
little is known about how this cancer responds to cytotoxic
chemotherapy. We report the case of a 56-year-old male who
presented to our clinic with hemoptysis, cough and hematuria
and was found to have metastatic ductal carcinoma of the prostate.
He was initiated on docetaxel chemotherapy, which has been
previously shown to improve overall survival in patients with
metastatic prostate adenocarcinoma, but has never been studied
in this less common subtype of prostate cancer. To the best of
our knowledge, the following is the first reported case of a patient
with metastatic ductal carcinoma of the prostate responding to
docetaxel chemotherapy.
Downloads
Downloads
How to Cite
Issue
Section
License
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.